XML 48 R34.htm IDEA: XBRL DOCUMENT v3.22.4
Share-Based Compensation (Tables)
12 Months Ended
Nov. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Compensation Expense A summary of share-based compensation expense in the Consolidated Statements of Operations for TD SYNNEX stock incentive plans is presented below:
Fiscal Years Ended November 30,
202220212020
Selling, general and administrative expenses$38,994 $33,078 $17,631 
Acquisition, integration and restructuring costs (on awards issued in connection with the Merger)$6,514 $8,289 $— 
Total share-based compensation expense$45,508 $41,367 $17,631 
Summary of Changes in Company Stock Option Activity
A summary of the changes in the Company’s stock options is set forth below:
Options Outstanding
(number of shares in thousands) Number of
shares
Weighted-
average exercise
price per share
Balances, November 30, 2021689$66.29 
Options granted7290.16 
Options exercised(84)38.40 
Balances, November 30, 2022677$72.29 
Schedule of Assumptions Used in Black-Scholes Valuation Model
The Company did not grant any options during the fiscal year 2020. The following assumptions were used in the Black-Scholes valuation model in fiscal years 2022 and 2021:
Fiscal Years Ended November 30,
20222021
Expected life (years)5.5
5.5 - 6.1
Risk free interest rate
1.73% - 3.92%
0.72% - 1.16%
Expected volatility
39.10% - 40.18%
38.01% - 38.85%
Dividend yield
1.13% - 1.37%
0.75% - 0.88%
Schedule of Cash Received from Exercise of Options and intrinsic Values of Options Exercised
The cash received from the exercise of options and the intrinsic values of options exercised during fiscal years 2022, 2021 and 2020 were as follows:
Fiscal Years Ended November 30,
202220212020
Intrinsic value of options exercised$4,682 $16,163 $15,746 
Cash received from exercise of options$3,216 $10,541 $9,018 
Summary Changes in Non-vested Restricted Stock Awards and Stock Units
A summary of the changes in the Company’s non-vested RSAs and RSUs during fiscal year 2022 is presented below:
Number of
shares
Weighted-average,
grant-date
fair value per share
Non-vested as of November 30, 20211,066$100.20 
RSAs granted34188.64 
RSUs granted35099.12 
RSAs and RSUs vested(353)93.23 
RSAs and RSUs cancelled/forfeited(1)
(97)74.87 
Non-vested as of November 30, 20221,307$95.69 
__________________
(1) For performance-based RSUs, the difference between maximum awards and the actual number of shares issued upon full vesting is included.
The following table summarizes the activity related to these restricted shares during the year ended November 30, 2022:
(in thousands) Restricted shares
Nonvested at November 30, 2021
751
Vested(363)
Canceled(38)
Nonvested at November 30, 2022
350